multiple electrode aggregometry with adp stimuli meaadp (Dynabyte GmbH)
Structured Review
Multiple Electrode Aggregometry With Adp Stimuli Meaadp, supplied by Dynabyte GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+electrode+aggregometry/multiple+electrode+aggregometry+with+adp+stimuli+meaadp/pm20826265-39-40-43
Average 90 stars, based on 1 article reviews
Images
Related Articles
Transmission Assay:Article Title: Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis. Article Snippet: Background A growing number of observational studies suggest that high on-clopidogrel platelet reactivity (HPR) is associated with recurrent thrombotic events after percutaneous coronary intervention.. We aimed to perform an updated systematic review and meta-analysis on the clinical relevance of HPR to summarize the available evidence and to define more precise effect estimates.. Methods Relevant observational studies published between January 2003 and February 2010 were searched that presented intent-to-treat analyses on the clinical relevance of HPR measured with an adenosine diphosphate (ADP)–specific platelet function assay. Phospho-proteomics:Article Title: Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis. Article Snippet: Background A growing number of observational studies suggest that high on-clopidogrel platelet reactivity (HPR) is associated with recurrent thrombotic events after percutaneous coronary intervention.. We aimed to perform an updated systematic review and meta-analysis on the clinical relevance of HPR to summarize the available evidence and to define more precise effect estimates.. Methods Relevant observational studies published between January 2003 and February 2010 were searched that presented intent-to-treat analyses on the clinical relevance of HPR measured with an adenosine diphosphate (ADP)–specific platelet function assay. |
